Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study

This study evaluated the efficacy and safety of tadalafil in pediatric patients with pulmonary arterial hypertension. This phase-3, international, randomized, multicenter (24 weeks double-blind placebo-controlled period; two-year, open-labeled extension period), add-on (patient’s current endothelin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivy, Dunbar, Bonnet, Damien, Berger, Rolf MF, Meyer, Gisela M.B., Baygani, Simin, Li, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226239/
https://www.ncbi.nlm.nih.gov/pubmed/34234945
http://dx.doi.org/10.1177/20458940211024955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226239/
https://www.ncbi.nlm.nih.gov/pubmed/34234945
http://dx.doi.org/10.1177/20458940211024955

Ejemplares similares